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CHO-Chr6 (100 Gy) X A23huCD80 huBTN3A1 (A23) Test and dilution 30-6 (100 Gy) x (A23) Test and dilution 30-6_10-2-3 (300 Gy) x (A23) 30- 6_100-7 Test and dilution 96 vs >>150 pg/mL RNASeq Test and dilution 16 vs >>150 30-6_10-2-3_20-20-45 vs >>200 pg/mL 30-6_10-2-3_20-46-57 vs >>200 pg/mL 30-6_10-2-3_20-46 56 vs >>200 pg/mL CHO-Chr6 (100 Gy) X BWratCD80 huBTN3A1 Test and dilution RNASeq RNASeq BW-2-1-2 2 vs 14 pg/mL BW-2-10-1 5 vs 150 pg/mL 2 6 0 1 6 3 7 9 2 6 0 5 5 7 8 7 2 6 1 6 4 0 7 2 2 6 2 0 4 5 5 2 2 6 2 5 0 1 9 5 2 6 4 0 2 2 3 7 2 6 6 0 2 7 3 3 production (pg/ml) in the stimulation assay in the presence of medium or with 1 μM HMBPP. (B) Region of human Chr 6 implicated in potentiation of P-Ag sensitisation by rodent-human radiation hybrids. Each dot represents a gene detected as ≥3 transcripts, with those highlighted in pink detected in every P-Ag-sensitizeable clone selected for analysis. Figure 5D . 
